双相情感障碍
青少年躁狂量表
电休克疗法
狂躁
全球功能评估
萧条(经济学)
心情
心理学
情绪稳定器
情感障碍症
内科学
汉密尔顿抑郁量表
临床终点
轻躁症
医学
精神科
重性抑郁障碍
随机对照试验
精神分裂症(面向对象编程)
经济
宏观经济学
作者
Dario Delmonte,S. Brioschi,Barbara Barbini,Raffaella Zanardi,Cristina Colombo
出处
期刊:European Psychiatry
[Cambridge University Press]
日期:2017-04-01
卷期号:41 (S1): S768-S768
被引量:1
标识
DOI:10.1016/j.eurpsy.2017.01.1448
摘要
Introduction Despite appropriate treatment, 30–40% of depressed patients, both unipolar and bipolar, do not achieve improvement, with high morbidity and mortality. For bipolar patients another risk is the switch into mania due to antidepressant treatment. The concern about the switch, suggests to administer antidepressants at lower doses, in combination with mood stabilizers and second generation anti-psychotics. Objectives We performed an observational study on a sample of 23 bipolar patients treated with ECT for severe TRD in last 3 years, in order to evaluate the risk of switch. Methods Twenty-three bipolar inpatients, undergoing bitemporal ECT twice/week, with MECTA spectrum device. Main demographic and clinical data collected. Hamilton rating scale for depression (HAM-D). Clinical response defined as 50% reduction of HAM-D score at the endpoint from baseline; remission as HAM-D score at the endpoint < 8. Young Mania rating scale (YMRS) weekly in order to assess switch into mania. Results Thirteen (56.5%) females, 10 (43.5%) males, mean age 60.1 ± 10.3 years. Mean age at onset 35.5 ± 13.6 years. Mean number of episodes: 7.1 ± 3.6. Mean duration of current episode: 33.4 ± 24.9 weeks. Mean HAM-D basal score: 30.0 ± 5. Each patient underwent a cycle of ECT (mean No. 6.7 ± 3.3). Pharmacological treatment was administered upon clinical need. Response rate 87%, remission rate 43.5%. Three out of 23 (13.04%) patients had transient hypomanic switch, spontaneous recovery within 7 days after the last ECT. Conclusions Our experience confirms that ECT is a powerful antidepressant, especially in patients with severe long-lasting depression, refractory to treatment. ECT is also a safe procedure: no adverse effects were reported. The manic switch rate is comparable with antidepressant drugs. Disclosure of interest The authors have not supplied their declaration of competing interest.
科研通智能强力驱动
Strongly Powered by AbleSci AI